Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCAPE-SHF: Aliskiren and Ramipril in Decompensated Systolic Heart Failure
NCT00923156Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of aliskiren, sponsored by Novartis. Started May 2009; status: completed.
02
Drugs
aliskiren
Beyond the preview
Go deeper on NCT00923156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00923156.